COPD

Not all that glitters is GOLD, prevalence of asthma-COPD overlap in primary care, and 4 more new studies in COPD, asthma, and overlap highlighted. 

Are you up-to-date on the latest COPD research? Brush-up with this quick, 5-question quiz. 

Second-hand smoke and COPD, optimal cutoff for COPD diagnosis, impact of exercise on COPD risk, and 3 more new findings, at-a-glance.

Confirmed: FEV1:FVC <0.70 proves to be the optimal threshold to identify risk of COPD vs less than LLN and other fixed values.

The 2019 GOLD Guidelines make a new distinction in how to choose initial and subsequent COPD treatment. Do you know what that is? Answer and 4 more questions, here.

Consequences of a late COPD diagnosis, a blood test to stratify mortality risk, and 6 other new studies offer insights into improving care for COPD patients.

DALLAS--Results of 3 studies presented at the American Thoracic Society meeting this week focus on the predictive role of disease exacerbations, machine learning, and Hgb levels in COPD. 

Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.

More than one-third of those in recovery from drug/alcohol use have chronic physical disease. A novel study looks at prevalence of health issues by type of substance used.

Answers to these 5 questions on new research may have you re-thinking treatment strategies for your COPD patients.

"I'm having trouble catching my breath." "I can't pay for my inhaler." "I'm just so sad." They may not tell us, so we need to ask. Here's my experience.

Topics include: Role of antibiotics for acute exacerbations; updates on long-term oxygen therapy; COPD-PCI connection, plus more.

Take this short 5-question quiz to find out what you know--or, what you may have missed--about the latest developments in COPD.

These brief summaries highlight key developments in COPD and how they are likely to affect patient management in the months and years ahead.

Pulmonologist Jonathan Ilowite, MD, answers 5 of the many common questions he fields about COPD exacerbations and how to manage them.

Find out what you know about the 2018 revisions to the GOLD guidelines and the recommended changes for patient care. 

An app that tracks cigarette cravings and moods, one that guides patients through proper inhaler use, and 3 other top COPD apps for both patients and physicians. 

Try these 5 questions written by a pulmonologist and based on updates to the GOLD guidelines on how to classify and manage COPD.

Beth is age 52, smokes 2 packs of cigarettes a day, gets breathless in cold weather, and has had "bronchitis" twice this year. What's your diagnosis?

A pulmonologist answers some of the most common questions he hears from colleagues and students about COPD exacerbations and their management.

COPD… nasal polyps.. gout …. dyskinesia in Parkinson Disease: here’s a brief look at new drugs for these and other disorders coming your way.

HRT, tattoos, insurers exacerbating the opioid epidemic, prolonged sitting, plus a new COPD drug: here's a recap of 5 of the week's key news reports.

Among the 13 new genes identified in this genome-wide association study, 4 have never before been linked to lung function.

A new study reports the impact on work productivity and lifestyle of undertreated COPD in the US, Europe, and China.

Take this quick quiz to test your knowledge of the disease and the latest guidance for improving patient care.

There are no optimal markers to predict mortality in COPD but results of a new study support further investigation of CRP.

Important revisions to the GOLD recommendations include a new definition of COPD and refined diagnostic categories.

A recent literature review found that up to 90% of COPD patients experience ADL-limiting morning symptoms.

Results of a new study suggest that racial inequalities in COPD, especially in women, may be shaped by socioeconomic factors.

The Breathlessness, Cough and Sputum Scale, used to evaluate COPD treatment efficacy, may help predict exacerbations in severe disease.